Dr. Sam Bailey: Project Veritas and the “Virus”

Dr. Sam Bailey, MD and her colleagues believe that the virus and germ theory have been completely dismantled and it is a matter of time before it is more widely known. She said that the freedom community has only partially woken up to the propaganda about the COVID ‘virus’ that has dominated the media for three years. She said that the latest sting video from Project Veritas featuring Dr. Jordan Walker exposing Pfizer for trying to create new viruses in order to profit from new vaccines through ‘directed evolution’ was more propaganda. Walker presented zero evidence that the a virus mutates or could be engineered. The gain of function narrative has been used to gaslight people who know that there is something wrong with the official story. The purpose of promoting the virus theory is to gain power over people through masks, vaccines, surveillance and vaccine passports.

She said that the Project Veritas story was only pseudo-censored as it reached millions of people.  Meanwhile, she stated that the no-virus argument is the most censored of all and could destroy the market for childhood vaccines.

Link for video:    https://www.bitchute.com/video/rASg28ubQk7X/




Brain Implant Startup Backed by Gates and Bezos Is Testing Mind-Controlled Computing on Humans

Synchron is part of the brain-computer interface industry (BCI) that deciphers brain signals and translates them into commands for external technologies. The system is implanted through the blood vessels, rather than open brain surgery or burr holes. It allows patients to operate technology using only their minds. Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos contributed to Synchron’s latest $75 million financing round. Synchron became the first company to receive an Investigational Device Exemption from the FDA to conduct trials of a permanently implantable BCI in human patients. So far, the technology has been used on three patients in the U.S. and four in Australia.

.

In a Brooklyn lab stuffed with 3D printers and a makeshift pickleball court, employees at a brain interface startup called Synchron are working on technology designed to transform daily life for people with paralysis.

The Synchron Switch is implanted through the blood vessels to allow people with no or very limited physical mobility to operate technology such as cursors and smart home devices using their mind. So far, the nascent technology has been used on three patients in the U.S. and four in Australia.

“I’ve seen moments between patient and partner, or patient and spouse, where it’s incredibly joyful and empowering to have regained an ability to be a little bit more independent than before,” Synchron CEO Tom Oxley told CNBC in an interview. “It helps them engage in ways that we take for granted.”

Founded in 2012, Synchron is part of the burgeoning brain-computer interface, or BCI, industry. A BCI is a system that deciphers brain signals and translates them into commands for external technologies. Perhaps the best-known name in the space is Neuralink, thanks to the high profile of founder Elon Musk, who is also the CEO of Tesla, SpaceX and Twitter.

But Musk isn’t the only tech billionaire wagering on the eventual transition of BCI from radical science experiment to flourishing medical business. In December, Synchron announced a $75 million financing round that included funding from the investment firms of Microsoft co-founder Bill Gates and Amazon

founder Jeff Bezos.

‘More scalable’

In August 2020, the Food and Drug Administration granted Synchron the Breakthrough Device designation, which is for medical devices that have the potential to provide improved treatment for debilitating or life-threatening conditions. The following year, Synchron became the first company to receive an Investigational Device Exemption from the FDA to conduct trials of a permanently implantable BCI in human patients.

Synchron is enrolling patients in an early feasibility trial, which aims to show that the technology is safe to put in humans. Six patients will be implanted with Synchron’s BCI during the study, and Chief Commercial Officer Kurt Haggstrom said the company is currently about halfway through.

Read full article here…